HRT Financial’s TriSalus Life Sciences TLSI Stock Holding History

HRT Financial’s Portfolio TLSI Stock Details TLSI Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2025 Q2	–	Sell	-13,657	Closed	-$75K	–	3515
2025 Q1	$75K	Buy	+13,657	New	+$72.7K	﹤0.01%	2193
2024 Q4	–	Sell	-15,575	Closed	-$71K	–	3244
2024 Q3	$71K	Sell	15,575 -19,966	-56%	-$106K	﹤0.01%	2075
2024 Q2	$196K	Buy	+35,541	New	+$301K	﹤0.01%	1666
2024 Q1	–	Sell	-48,011	Closed	-$405K	–	3083
2023 Q4	$405K	Buy	+48,011	New	+$247K	﹤0.01%	1471

Other funds holding TLSI

NCM

Nantahala Capital Management New Canaan, Connecticut $2.72B AUM 121.58% 1-Year Est. Return

AIC

AWM Investment Company New York $903M AUM 163.47% 1-Year Est. Return

GGHC

Gilder Gagnon Howe & Co New York $8.34B AUM 46.58% 1-Year Est. Return

Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return

WAP

Wealthcare Advisory Partners West Chester, Pennsylvania $5.27B AUM 22.23% 1-Year Est. Return

BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Alyeska Investment Group Chicago, Illinois $35.4B AUM 33.54% 1-Year Est. Return

Geode Capital Management Boston, Massachusetts $1.61T AUM 30.72% 1-Year Est. Return

Bank of America Charlotte, North Carolina $1.37T AUM 24.88% 1-Year Est. Return

Northern Trust Chicago, Illinois $757B AUM 28.64% 1-Year Est. Return

HRT Financial's TLSI Position: Q2 2025 in Review

HRT Financial sold out of TriSalus Life Sciences (TLSI) in Q2 2025, closing a stake of 13,657 shares — an estimated $75K sold.

HRT Financial first reported a position in TLSI in Q4 2023 and held it in 4 quarters. The position peaked at $405K in Q4 2023. 48 funds tracked by Wall St. Rank hold TLSI as of Q2 2025.

HRT Financial reported no remaining TriSalus Life Sciences position as of Q2 2025 after selling out during the quarter.
HRT Financial sold 13,657 TriSalus Life Sciences shares in Q2 2025, an estimated $75K.
HRT Financial first reported a position in TriSalus Life Sciences in Q4 2023 and held it in 4 quarters.
HRT Financial's TriSalus Life Sciences position peaked at $405K in Q4 2023.
48 funds tracked by Wall St. Rank held TriSalus Life Sciences as of Q2 2025.

Based on HRT Financial's 13F filing for Q2 2025, filed 14 Aug 2025.